yanlin yu
National Institutes of Health (NIH)
Bethesda, United States
Review Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial Board
Type at least 3 characters
669 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
er yue
City of Hope National Medical Center
Duarte, United States
Review Editor
Cancer Molecular Targets and Therapeutics
maria zingariello
Campus Bio-Medico University
Rome, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
yekaterina y zaytseva
University of Kentucky
Lexington, United States
Review Editor
Cancer Molecular Targets and Therapeutics
ann zeuner
National Institute of Health (ISS)
Rome, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
shumei zhai
Shandong University
Jinan, China
Review Editor
Cancer Molecular Targets and Therapeutics
dalin zhang
Stanford University
Stanford, United States
Review Editor
Cancer Molecular Targets and Therapeutics
jian-ye zhang
Guangzhou Medical University
Guangzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
liang zhang
Mayo Clinic
Rochester, United States
Review Editor
Cancer Molecular Targets and Therapeutics
liqing zhang
Virginia Tech
Blacksburg, United States
Review Editor
Cancer Molecular Targets and Therapeutics
qiong zhang
Albert Einstein College of Medicine
New York City, United States
Review Editor
Cancer Molecular Targets and Therapeutics
shuai zhang
Affiliated Hospital of Guizhou Medical University
Guiyang, China
Review Editor
Cancer Molecular Targets and Therapeutics
tiantian zhang
Weill Cornell Medicine, Cornell University
New York, United States
Review Editor
Cancer Molecular Targets and Therapeutics
xingding zhang
School of medicine, Sun Yat-sen University
Shenzhen, China
Review Editor
Cancer Molecular Targets and Therapeutics
yijian zhang
Shanghai Jiao Tong University
Shanghai, China
Review Editor
Cancer Molecular Targets and Therapeutics
zhifang zhang
City of Hope National Medical Center
Duarte, United States
Review Editor
Cancer Molecular Targets and Therapeutics